Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohsen Rashidi

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Environmental Research|June 22, 2023
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategiesMehrdad Hashemi, Sahar Abbaszadeh, Mohsen Rashidi, et al.
Environmental Research|September 16, 2023
Multifunctional and theranostic hydrogels for wound healing acceleration: An emphasis on diabetic-related chronic woundsPooya M Tehrany, Parham Rahmanian, Aryan Rezaee, et al.
Mutation Research. Reviews in Mutation Research|August 31, 2024
Mechanistic insights into cisplatin response in breast tumors: Molecular determinants and drug/nanotechnology-based therapeutic opportunitiesMehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mehrnaz Kalhor Chegini, et al.
Heliyon|September 23, 2024
Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapyMehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mahsa Tanha, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 21, 2023
Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategiesMehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, et al.
Pharmacological Research|November 18, 2022
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and ChallengesMahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 7, 2023
Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospectiveMehrdad Hashemi, Mohammad Arad Zandieh, Setayesh Ziaolhagh, et al.
The International Journal of Biochemistry & Cell Biology|March 21, 2024
Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factorsMehrdad Hashemi, Pouria Daneii, Mahya Asadalizadeh, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 27, 2023
Epigenetic regulation of temozolomide resistance in human cancers with an emphasis on brain tumors: Function of non-coding RNAsAryan Rezaee, Pooya M Tehrany, Farimah Jafari Tirabadi, et al.
Cellular & Molecular Biology Letters|April 21, 2023
Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significanceMehrdad Hashemi, Eisa Sabouni, Parham Rahmanian, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Environmental Research|June 22, 2023
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategiesMehrdad Hashemi, Sahar Abbaszadeh, Mohsen Rashidi, et al.
Environmental Research|September 16, 2023
Multifunctional and theranostic hydrogels for wound healing acceleration: An emphasis on diabetic-related chronic woundsPooya M Tehrany, Parham Rahmanian, Aryan Rezaee, et al.
Mutation Research. Reviews in Mutation Research|August 31, 2024
Mechanistic insights into cisplatin response in breast tumors: Molecular determinants and drug/nanotechnology-based therapeutic opportunitiesMehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mehrnaz Kalhor Chegini, et al.
Heliyon|September 23, 2024
Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapyMehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mahsa Tanha, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 21, 2023
Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategiesMehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, et al.
Pharmacological Research|November 18, 2022
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and ChallengesMahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 7, 2023
Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospectiveMehrdad Hashemi, Mohammad Arad Zandieh, Setayesh Ziaolhagh, et al.
The International Journal of Biochemistry & Cell Biology|March 21, 2024
Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factorsMehrdad Hashemi, Pouria Daneii, Mahya Asadalizadeh, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 27, 2023
Epigenetic regulation of temozolomide resistance in human cancers with an emphasis on brain tumors: Function of non-coding RNAsAryan Rezaee, Pooya M Tehrany, Farimah Jafari Tirabadi, et al.
Cellular & Molecular Biology Letters|April 21, 2023
Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significanceMehrdad Hashemi, Eisa Sabouni, Parham Rahmanian, et al.
Pageof 10